UNSPSC 51351517: Hydroxyprogesterone

This classification denotes a therapeutic progestin with the molecular formula C21H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21807M87J2, chemically known as 17-hydroxypregn-4-ene-3,20-dione but generally known as 17alpha-hydroxyprogesterone, which bears US NIH Compound Identifier 6238. European Medicines Agency schedules Hydroxyprogesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08081MIG. The term 17ALPHA-HYDROXYPROGESTERONE is an International Non-Proprietary Name.

UNSPSC 51351517 Hydroxyprogesterone is a Commodity code that captures state and local government procurement of the synthetic progestin medication hydroxyprogesterone caproate, used primarily for maternal health applications including prevention of preterm birth in high-risk pregnancies. State and local health departments, Medicaid agencies, public health clinics, and hospital systems acquire this pharmaceutical under the code, typically as part of broader pharmaceutical supply contracts or standalone specialty medication buys. The work involves sourcing, warehousing, and distribution of the drug to clinical facilities and outpatient obstetric programs.

The most-recent-state-local-contract-opportunities block contains no records for this code, indicating no active or recently closed state and local solicitations are currently indexed under UNSPSC 51351517. Without recent opportunities posted, characterization of issuing-body concentration, geographic spread, or representative recent procurements is not supported by the source.